{
    "organizations": [],
    "uuid": "ca30bb70f367371c69d4738ec8da48dd68372bd7",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-tapimmune-and-marker-therapeutics/brief-tapimmune-and-marker-therapeutics-announce-entry-into-merger-agreement-idUSFWN1SM0LQ",
    "ord_in_thread": 0,
    "title": "BRIEF-Tapimmune And Marker Therapeutics Announce Entry Into Merger Agreement",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 15 (Reuters) - TapImmune Inc:\n* TAPIMMUNE AND MARKER THERAPEUTICS ANNOUNCE ENTRY INTO MERGER AGREEMENT, CREATING A TRANSFORMATIONAL IMMUNO-ONCOLOGY PLATFORM\n* TAPIMMUNE - MARKER STOCKHOLDERS RECEIVE NEW SHARES, WARRANTS OF COâ€™S STOCK RELATED TO DEAL EQUAL TO NUMBER OF CO SHARES, WARRANTS OUTSTANDING AT DEAL CLOSE\n* TAPIMMUNE INC - PROPOSED DEAL TO BE A MERGER-OF-EQUALS UNDER WHICH STOCKHOLDERS OF TAPIMMUNE AND MARKER WILL EACH OWN ABOUT 50% OF COMBINED COMPANY Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\nOur Standards: The Thomson Reuters Trust Principles. ",
    "published": "2018-05-15T17:44:00.000+03:00",
    "crawled": "2018-05-16T19:17:49.021+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "tapimmune",
        "inc",
        "tapimmune",
        "marker",
        "therapeutic",
        "announce",
        "entry",
        "merger",
        "agreement",
        "creating",
        "transformational",
        "platform",
        "tapimmune",
        "marker",
        "stockholder",
        "receive",
        "new",
        "share",
        "warrant",
        "co",
        "stock",
        "related",
        "deal",
        "equal",
        "number",
        "co",
        "share",
        "warrant",
        "outstanding",
        "deal",
        "close",
        "tapimmune",
        "inc",
        "proposed",
        "deal",
        "stockholder",
        "tapimmune",
        "marker",
        "combined",
        "company",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}